Imris Inc. - Products
Imris design, manufacture and market the VISIUS Surgical TheatreTM, a multifunctional surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Designed to meet each hospital’s specific clinical application needs, the VISIUS Surgical Theatre can incorporate MR imaging, CT imaging and x-ray angiography in a number of configurations to provide intraoperative images of diagnostic quality - without introducing additional patient transport risk and delivering real-time information to clinicians while preserving optimal surgical access and techniques.
We sell our VISIUS Surgical Theatres globally to hospitals that deliver clinical services to patients in the neurosurgical, cerebrovascular and cardiovascular markets. We believe that the primary market for our current product portfolio is comprised of those hospitals having relatively large neurosurgical, cerebrovascular or cardiovascular practices.
We are committed to investing in research and development to further broaden our product portfolio and increase market penetration of our existing products.
Business Model
The purchase and installation of a VISIUS Surgical Theatre represents a significant capital project for Imris customers that can range in price from approximately $4 million to $12 million depending on the product solution, the configuration of the VISIUS Surgical Theatre layout and system options selected. In addition to the capital equipment sale, most of our customers enter into equipment service contracts that are generally 4-5 years in duration. These contracts begin after the typical one-year warranty period and are on average equal to approximately 5% of the original equipment purchase price per year in revenues. In addition to our equipment and services, customers may require further capital expenditures for construction and ancillary equipment. The sales cycle for our VISIUS Surgical Theatres is both complex and lengthy and can be more than 12 months from initial customer engagement to receipt of a purchase order.
To December 31, 2011, we had sold 49 VISIUS Surgical Theatres, of which 38 are installed and 11 are in the delivery phase. Of the 49 sold, 31 are in the United States, 8 are in Canada, 6 are in Asia Pacific and 4 are in Europe and the Middle East.
The above is excerpted from the company’s web site here:
imris.com
Three additional systems have been added to the company backlog during the first quarter of 2012, one each from the US, China and the Middle East, totaling about $22 million. |
